Quipt Home Medical Corp
QIPT2.740USD
0.000
Fechamento 09/19, 16:00（ET）Cotações atrasadas em 15 min
119.04MValor de mercado
PerdaP/L TTM
Mais detalhes de Quipt Home Medical Corp Empresa
Quipt Home Medical Corp. is a home medical equipment provider. The Company provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.
Informações da empresa
Código da empresaQIPT
Nome da EmpresaQuipt Home Medical Corp
Data de listagemMar 18, 2014
CEOMr. Gregory (Greg) Crawford
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 18
Endereço1019 Town Drive
CidadeWILDER
Bolsa de valoresThe Toronto Stock Exchange
PaísUnited States of America
Código postal41076
Telefone18598782220
Sitehttps://quipthomemedical.com/
Código da empresaQIPT
Data de listagemMar 18, 2014
CEOMr. Gregory (Greg) Crawford
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.16M
+46.29%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+49.93%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Mr. David Bachelder
Mr. David Bachelder
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Dr. Kevin A. Carter
Dr. Kevin A. Carter
Independent Director
Independent Director
--
--
Mr. Cole Stevens
Mr. Cole Stevens
Vice President - Corporate Development
Vice President - Corporate Development
--
--
Mr. Thomas W. Roehrig
Mr. Thomas W. Roehrig
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Brian J. Wessel
Mr. Brian J. Wessel
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Hardik Mehta
Mr. Hardik Mehta
Chief Financial Officer
Chief Financial Officer
1.16M
+46.29%
Mr. Mark Miles
Mr. Mark Miles
Chief Compliance Officer
Chief Compliance Officer
110.00K
--
Mr. Patrick Gamble
Mr. Patrick Gamble
Executive Vice President - Operations
Executive Vice President - Operations
60.06K
+49.93%
Mr. Gregory (Greg) Crawford
Mr. Gregory (Greg) Crawford
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Mr. Mark Greenberg
Mr. Mark Greenberg
Independent Director
Independent Director
--
--
Mr. David Bachelder
Mr. David Bachelder
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 23 de ago
Atualizado em: sáb, 23 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Claret Asset Management Corporation
9.75%
Forager Capital Management, LLC
9.67%
Crawford (Gregory John)
9.22%
Kanen Wealth Management, LLC
4.44%
First Manhattan Co. LLC
3.80%
Outro
63.12%
Investidores
Investidores
Proporção
Claret Asset Management Corporation
9.75%
Forager Capital Management, LLC
9.67%
Crawford (Gregory John)
9.22%
Kanen Wealth Management, LLC
4.44%
First Manhattan Co. LLC
3.80%
Outro
63.12%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
21.23%
Investment Advisor
19.95%
Individual Investor
15.18%
Hedge Fund
3.68%
Research Firm
1.66%
Private Equity
1.17%
Bank and Trust
0.47%
Venture Capital
0.09%
Outro
36.57%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
205
30.42M
70.02%
-4.48M
2025Q1
222
32.65M
75.41%
-3.29M
2024Q4
219
27.04M
62.76%
-4.70M
2024Q3
209
25.69M
59.64%
-2.81M
2024Q2
198
23.34M
54.85%
-1.55M
2024Q1
194
21.73M
51.56%
-2.58M
2023Q4
189
20.79M
49.92%
-2.91M
2023Q3
186
21.87M
52.48%
+145.17K
2023Q2
175
20.15M
48.43%
+2.87M
2023Q1
115
15.73M
43.04%
+2.14M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Claret Asset Management Corporation
4.32M
9.93%
-74.19K
-1.69%
May 31, 2025
Forager Capital Management, LLC
4.20M
9.67%
--
--
Jun 04, 2025
Crawford (Gregory John)
4.01M
9.22%
+1.05M
+35.73%
Mar 22, 2025
Kanen Wealth Management, LLC
1.93M
4.44%
-1.04M
-35.07%
May 27, 2025
First Manhattan Co. LLC
1.65M
3.8%
--
--
Mar 31, 2025
Mehta (Hardik)
1.16M
2.67%
+366.47K
+46.29%
Mar 22, 2025
Royce Investment Partners
1.95M
4.49%
-32.10K
-1.62%
Mar 31, 2025
Putnam Investment Management, L.L.C.
703.72K
1.62%
-26.10K
-3.58%
Mar 31, 2025
Arrowstreet Capital, Limited Partnership
578.92K
1.33%
+85.06K
+17.22%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
